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ractional Flow Reserve–Guided Versus Intravascular Ultrasound–Guided
hang-Wook Nam, MD, PHD,* Hyuck-Jun Yoon, MD,* Yun-Kyeong Cho, MD, PHD,*
young-Seob Park, MD,* Hyungseop Kim, MD, PHD,* Seung-Ho Hur, MD, PHD,*
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bjectives This study sought to evaluate the long-term clinical outcomes of a fractional ﬂow re-
erve (FFR)–guided percutaneous coronary intervention (PCI) strategy compared with intravascular
ltrasound (IVUS)–guided PCI for intermediate coronary lesions.
ackground Both FFR- and IVUS-guided PCI strategies have been reported to be safe and effective
n intermediate coronary lesions.
ethods The study included 167 consecutive patients, with intermediate coronary lesions evalu-
ted by FFR or IVUS (FFR-guided, 83 lesions vs. IVUS-guided, 94 lesions). Cutoff value of FFR in FFR-
uided PCI was 0.80, whereas that for minimal lumen cross sectional area in IVUS-guided PCI was
.0 mm2. The primary outcome was deﬁned as a composite of major adverse cardiac events includ-
ng death, myocardial infarction, and ischemia-driven target vessel revascularization at 1 year after
he index procedure.
esults Baseline percent diameter stenosis and lesion length were similar in both groups (51  8%
nd 24  12 mm in the FFR group vs. 52  8% and 24  13 mm in the IVUS group, respectively).
owever, the IVUS-guided group underwent revascularization therapy signiﬁcantly more often
91.5% vs. 33.7%, p  0.001). No signiﬁcant difference was found in major adverse cardiac event
ates between the 2 groups (3.6% in FFR-guided PCI vs. 3.2% in IVUS-guided PCI). Independent pre-
ictors for performing intervention were guiding device: FFR versus IVUS (relative risk [RR]: 0.02); left
nterior descending coronary artery versus non-left anterior descending coronary artery disease (RR:
.60); and multi- versus single-vessel disease (RR: 3.28).
onclusions Both FFR- and IVUS-guided PCI strategy for intermediate coronary artery disease were
ssociated with favorable outcomes. The FFR-guided PCI reduces the need for revascularization of
any of these lesions. (J Am Coll Cardiol Intv 2010;3:812–7) © 2010 by the American College of
ardiology Foundation
rom the *Keimyung University Dongsan Medical Center, Daegu, Korea; †Seoul National University Hospital, Seoul, Korea;
Ajou University Hospital, Suwon, Korea; and the §Stanford University Medical Center, Cardiovascular Medicine, Stanford,
alifornia. Dr. Yoon-Nyun Kim has received research grant no. RTI04-01-01 from the Regional Technology Innovation Program
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813ecause of the limitations of coronary angiography (1),
djunctive techniques to more accurately evaluate lesion
everity are important in patients with intermediate coro-
ary stenosis before percutaneous coronary intervention
PCI). Fractional flow reserve (FFR) has been the reference
tandard for the physiological assessment of coronary artery
tenosis, particularly intermediate ones (2–4). Deferring
ntervention of intermediate coronary lesions with a FFR
0.75 or 0.80 is associated with favorable long-term clinical
utcomes (5,6). An intravascular ultrasound (IVUS)–
See page 818
erived minimal lumen area (MLA)4.0 mm2, or minimal
umen diameter 1.8 mm have been shown to correlate
ith a FFR 0.75 (7), and deferring intervention in
ntermediate coronary lesions based on MLA 4.0 mm2
esults in favorable clinical outcomes (8). However, there are
ew studies that compared FFR- and IVUS-guided coro-
ary intervention strategies in patients with de novo coro-
ary intermediate lesions. The aim of this study was to
valuate the clinical outcomes of a FFR- versus IVUS-
uided PCI strategy for intermediate coronary lesions.
ethods
atient population and study design. The patient popula-
ion consisted of 167 consecutive patients (177 lesions) who
nderwent FFR or IVUS assessment to decide whether to
erform PCI or not for de novo intermediate coronary
esions between August 2006 and June 2008. An interme-
iate coronary lesion was defined as 40% to 70% diameter
tenosis by visual assessment. For this study, the target
essel was a single lesion in the proximal or mid part of a
ajor epicardial coronary artery with reference vessel diam-
ter larger than 2.5 mm. The lesion had no documented
vidence of ischemia by noninvasive tests (not performed,
egative, inadequate, or not evaluable for a target lesion).
atients were not eligible for enrollment if they: 1) had
ndergone intervention in the setting of primary or emer-
ent PCI for an acute coronary syndrome; 2) had prior
oronary artery bypass graft surgery; 3) had multiple lesions
n the same epicardial artery; 4) had left main disease,
rimary myocardial disease, or a major life threatening
llness; or 5) had contraindications to adenosine, aspirin, or
lopidogrel.
The use of FFR or IVUS was made based on operator
reference. The cutoff value of FFR in the FFR-guided PCI
roup was 0.80 (6,9,10) and that of MLA in the IVUS-
uided PCI was 4.0 mm2 (7,8). Implanted stents were
ommercially available drug-eluting stents (DES) in all
ases.
rocedural details. Coronary angiography was performed in
ultiple views after the intracoronary injection of 0.2 mg citroglycerin. Percutaneous coronary intervention was per-
ormed following standard interventional techniques. Anti-
latelet and antithrombotic agents were prescribed accord-
ng to current PCI guidelines (3). All coronary angiograms
ere analyzed using standard definitions and measurements
y quantitative coronary angiography (Quantcor QCA,
ersion 4.0, Pie Medical Imaging, Maastricht, the Nether-
ands) by an experienced physician who was blinded to the
ype of PCI guidance.
Fractional flow reserve was defined as the ratio between
ean distal coronary pressure and mean aortic pressure,
oth measured simultaneously at maximal hyperemia. Cor-
nary pressure was measured using a 0.014-inch sensor-
ipped PCI guidewire (Pressure Wire, Radi Medical Sys-
ems, Uppsala, Sweden). The wire was introduced through
6- or 7-F guiding catheter, equalized, and advanced distal
o the stenosis as previously described (9). The FFR value
as checked after administration of adenosine to induce
aximal hyperemia, either in-
ravenously (140 g/kg/min) or
ntracoronarily (40 g in the
ight, 80 g in the left coronary
rtery).
Intravascular ultrasound guid-
nce was performed using con-
entional 6- or 7-F guiding cath-
ters and a 0.014-mm guidewire
ositioned distally, and IVUS
atheters of 30 or 40 MHz (Bos-
on Scientific Corp., Natick, Mas-
achusetts) pulled back automati-
ally at a constant speed of 0.5
m/s. The lesion site selected for
nalysis was the image slice with
LA and minimal stent area,
hich were measured following
he guidelines for IVUS measurements by the American
ollege of Cardiology (11).
eﬁnitions and study outcomes. The primary outcome was
efined as a composite of major adverse cardiac events
MACE), defined as death, myocardial infarction, and
schemia-driven target vessel revascularization (TVR) at 12
onths after the index procedure. Death was defined as
ll-cause mortality. The diagnosis of myocardial infarction
as based on either the development of new pathological Q
aves in 2 contiguous electrocardiogram leads and/or
ardiac enzyme level elevation 3 times the upper limit of
ormal value. TVR included target lesion PCI and bypass
urgery of the target lesion. TVR was performed only in the
resence of symptoms and/or signs of ischemia. Stent
hrombosis was defined according to the Academic Re-
earch Consortium guidelines (12).
tatistical analyses. Data are expressed as mean  SD for
Abbreviations
and Acronyms
DES  drug-eluting stent(s)




LAD  left anterior
descending coronary artery
MACE  major adverse
cardiac event
MLA  minimal lumen area
PCI  percutaneous
coronary intervention
TVR  target vessel
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814bles. Continuous variables were compared using Student
test. Categorical variables were compared using chi-square
ests or Fisher exact test, as appropriate. All calculated
values were 2-sided and differences were considered to be
tatistically significant when the respective p values were
0.05. Multivariate logistic regression analysis was used to
ssess independent predictors of performing PCI and of
ACE. The parameters analyzed in multivariate analysis
ere selected when p value was lesser than 0.5 in univariate
nalysis. All statistical analyses were performed using SPSS
ersion 15.0 for Windows (SPSS Inc., Chicago, Illinois).
esults
aseline clinical, angiographic, and procedural characteris-
ics are summarized in Tables 1 and 2. Among 167
onsecutive patients (177 lesions), 83 lesions were assessed




(n  94) p Value
Clinical
Age, yrs 63 9 62 9 0.50
Men 55 (66.3) 55 (58.5) 0.35
Diabetes 18 (21.7) 24 (25.5) 0.60
Hypertension 35 (42.2) 48 (51.1) 0.29
Hypercholesterolemia 13 (15.7) 14 (14.9) 1.00
Current smoking 27 (32.5) 34 (36.2) 0.64
Previous PCI 17 (20.5) 12 (12.8) 0.22
Clinical presentation 0.22
Stable angina 38 (45.8) 34 (36.2)
Acute coronary syndrome 45 (54.2) 60 (63.8)
LVEF, % 61 10 59 10 0.14
Angiography
Extent of disease 0.02
Single 28 (33.7) 48 (51.1)
Multi 55 (66.3) 46 (48.9)
Target vessel 0.18
LAD 40 (48.2) 55 (58.5)
Non-LAD 43 (51.8) 39 (41.5)
Lesion location 0.77
Proximal 40 (48.2) 43 (45.7)
Mid 43 (51.8) 51 (54.3)
Lesion type* 0.87
Simple 25 (30.1) 30 (31.9)
Complex 58 (69.9) 64 (68.1)
Lesion length, mm 24 12 24 13 0.92
Reference vessel diameter, mm 3.23 0.43 3.39 0.49 0.03
Minimal lumen diameter, mm 1.59 0.32 1.61 0.45 0.68
Percent diameter stenosis, % 51 8 52 8 0.53
Values are mean  SD or n (%). *According to the American College of Cardiology/American
Heart Association classification, type A and B1 lesions are simple, whereas type B2 and C lesions
are complex.
FFR  fractional flow reserve; IVUS  intravascular ultrasound; LAD  left anterior descending(coronary artery; LVEF left ventricular ejection fraction; PCI percutaneous coronary intervention.y FFR and 94 lesions by IVUS. Intracoronary adenosine
as used in 79 lesions to induce maximal hyperemia. The
esulting groups were well matched without significant
ifferences in the frequency of clinical cardiovascular risk
actors. The incidence of multivessel disease was significantly
igher in the FFR group (66.3% vs. 48.9%, p  0.02). The
ost common target lesion location was the left anterior
escending coronary artery (LAD) in both groups (48.2% in
he FFR group vs. 58.8% in the IVUS group, p  0.18).
here was no significant difference in clinical presentation.
oth groups had similar percent diameter stenosis (51 
% vs. 52  8% in the FFR and IVUS groups respec-
ively, p  0.53). However, reference vessel diameter was
arger in the IVUS-guided group (3.39  0.49 mm vs.
.23  0.43 mm, p  0.03). Although angiographic
esion length was similar between 2 groups, IVUS lesion
ength was slightly longer than angiographic lesion length
n IVUS group (23.5  12.7 mm in angiographic lesion
ength vs. 25.3 11.0 mm in IVUS lesion length, p 0.008).
he incidence of performing PCI was much lower in the
FR-guided group (33.7% vs. 91.5%, p 0.001) as shown in
igure 1. The mean FFR value of deferred lesions was 0.87
.06 whereas that of revascularized lesions was 0.72  0.07 in
he FFR-guided group. The mean MLA of deferred lesions
as 5.1  1.5 mm2 and that of lesions treated by PCI was
.9 0.9 mm2 in the IVUS-guided group (Table 2). When
valuating LAD lesions alone, the frequency of PCI con-
inued to be greater with IVUS guidance compared with
FR guidance (52.5% in FFR group vs. 90.9% in IVUS
roup, p  0.001).
The 12-month clinical outcomes are summarized in
igure 2. There were no significant differences in TVR












Pre-intervention 0.87 0.06 0.72 0.07
Post-intervention 0.91 0.05
IVUS, mm2
Pre-interventional MLA 5.1 1.5 2.9 0.9
Post-interventional MSA 7.3 2.8
Stent number 1.1 0.5 1.1 0.5 0.97
Stent length, mm 31 13 28 14 0.42
Stent size, mm 3.2 0.4 3.3 0.5 0.16
Post-intervention
MLD, mm 2.89 0.42 3.03 0.47 0.19
DS, % 11 4 11 3 0.45
Values are mean SD.
DS  percent diameter stenosis; MLA  minimal lumen diameter; MLD  minimal lumen
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815nd MACE (3.6% in FFR group vs. 3.2% in IVUS group,
 1.00) between the 2 groups. The 3 TVR cases in the
FR-guided group were due to in-stent restenosis, deferred
esion aggravation, and progression of a nontarget lesion.
he 2 TVR cases in the IVUS-guided group were secondary
o in-stent restenosis. One noncardiac death was observed
n the IVUS group, which was related to a respiratory
nfection. No myocardial infarction or stent thrombosis was
bserved in either group. Kaplan-Meier estimates of cumu-
ative freedom from MACE during 12-month follow-up are
hown in Figure 3.
In multivariate logistic regression analysis, performing
ntervention was significantly affected by FFR versus IVUS
Figure 1. The Rate of Performing PCI According to Type of
Guiding Device
The fractional ﬂow reserve (FFR)–guided group showed signiﬁcantly lower
rates of performing percutaneous coronary intervention (PCI) compared to
the intravascular ultrasound (IVUS)–guided group.
Figure 2. 1-Year Clinical Outcomes According to the Type of Guiding Devic
The FFR- and IVUS-guided groups demonstrated excellent 12-month clinical ou
MACE  major adverse cardiac event; MI  myocardial infarction; TVR  target vessuidance (relative risk [RR]: 0.02, 95% confidence interval
CI]: 0.01 to 0.07), LAD versus non-LAD lesion (RR:
.60, 95% CI: 1.98 to 15.80), and multi- versus single-vessel
isease (RR: 3.28, 95% CI: 1.02 to 10.60) (Table 3). No
ariable was related to MACE in univariate analysis.
iscussion
he major findings in the current study are: 1) FFR- or
VUS-guided PCI in patients with intermediate coronary
esions was associated with favorable clinical outcomes; and
) the rate of performed PCI in intermediate coronary
es without signiﬁcant between-group differences. All p values were 0.05.
Figure 3. Kaplan-Meier Survival Curves for Freedom From
Adverse Cardiac Events During 12 Months of Follow-Up
Kaplan-Meier survival curves for freedom from adverse cardiac events dur-
ing 12 months of follow-up for both groups. p  0.05. Abbreviations as in
Figure 1.e
tcom
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816esions was significantly lower in the FFR-guided compared
ith the IVUS-guided group without any increase of
dverse event rates according to established criteria.
Assessment of a coronary lesion with intermediate sever-
ty remains challenging for interventional cardiologists. The
linical importance of a mild-to-moderate coronary stenosis
as been increased by some who propose that acute myo-
ardial infarctions originate from such lesions (13,14). Some
rgue that for this reason, PCI with DES might be
eneficial for the patients with an intermediate coronary
esion (15,16). However, recent studies showed that stent-
ng intermediate stenoses, without demonstrating their
hysiologic significance, does not improve outcome (5,6),
nd optimal medical treatment might result in similar
utcomes (17). In this study, the overall incidence of
ACE at 1 year was very low, namely 3.4% (6 of 177
esions). Although 36% (63 of 177 lesions) of cases were
eferred, the MACE rate was similar or lower than the
esults of recent DES clinical trials. The MACE rate of
he deferral group was 3.2% (2 of 63) and similar to that of
he PCI group, which was 3.5% (4 of 114). In a pooled
nalysis in which outcomes after DES were evaluated from
randomized trials (16), the MACE rate of DES is similar
r even higher than that of FFR- or IVUS-guided deferral
roup in the current study. Therefore, FFR or IVUS
easurements can be helpful in guiding the clinical decision
rocess in patients with doubtful angiographic severity by
educing unnecessary stenting without increasing adverse
linical events.
By multivariate regression analysis, performing interven-
ion was more frequent in the IVUS-guided group, in an
AD lesion, or in patients with multivessel disease. The last
factors seem intuitive, because the LAD territory has a
Table 3. Predictors of Performing PCI in the Intermediate Coronary Lesions
Univariate Variables
Relative Risk 95% CI
Age, yrs 0.98 0.95–1.02
Men 1.30 0.69–2.45
Diabetes 0.74 0.36–1.45
Current smoking 1.46 0.75–2.84
ACS 1.81 0.96–3.38
LVEF 0.98 0.94–1.01
FFR (vs. IVUS) 0.02 0.01–0.07
Multi (vs. single) VD 0.77. 0.41–1.44
LAD (vs. non-LAD) lesion 2.56 1.36–4.82
Lesion type 1.71 0.88–3.30
Lesion length 1.01 0.99–1.04
Reference vessel diameter 1.77 0.87–3,61
All parameters described in this table did not have significant interactions with each other.
ACS acute coronary syndrome; CI confidence interval; VD vessel disease; other abbreviatarge burden of myocardium compared with that of other oajor coronary arteries, and multivessel disease patients
ave a higher chance of having a significant lesion, whether
ssessed by IVUS or FFR. In the current study, the rate of
CI was 3 times higher in the IVUS-guided group than in
he FFR-guided group. However, the MACE rate was not
ifferent between the 2 groups. Although there have been
everal studies reporting a good correlation between FFR-
nd IVUS-derived MLA for assessing coronary lesions
7,18), the cutoff point based on MLA 4.0 mm2 does not
eflect the location of a lesion or the amount of myocardium
ubtended by the vessel. When the rate of PCI was
eanalyzed according to reference vessel diameter (3.0 mm
r 3.0 mm) or lesion location (proximal or mid), the
esults did not change. Therefore, IVUS can overestimate
he clinical significance of intermediate coronary lesions
19) and likely explains the increased rate of PCI in this
roup. If MLA 3.0 mm2 was applied for the cutoff point
n the current study, as previously reported (20), the
ncidence of performing PCI might be decreased to 42.6%,
imilar to that of the FFR-guided group. When a cut-point
as used that resulted in equal PCI rates of FFR group,
LA 2.5 mm2 was the most indicated value. Unfortu-
ately, this retrospective pilot study was not powered to
etect a difference in clinical outcome. With larger numbers,
ne might anticipate that the excess PCI in the IVUS-
uided group would translate into an increase in the adverse
vent rate. This study further confirms the safety of defer-
ing PCI in nonischemia-producing lesions (21).
tudy limitations. First, it was a retrospective study. There
ere several different baseline characteristics such as a
igher incidence of single-vessel disease and larger reference
essel diameter in the IVUS group. Second, the decision to
elect IVUS or FFR was left at the discretion of the
Multivariate Variables
p Value Relative Risk 95% CI p Value
0.30 0.97 0.92–1.03 0.30
0.41 2.41 0.85–6.82 0.10
0.40 0.42 0.14–1.28 0.13
0.27 0.79 0.28–2.25 0.66
0.07 2.17 0.83–5.66 0.12
0.12 0.98 0.94–1.03 0.49
0.001 0.02 0.01–0.07 0.001
0.41 3.28 1.02–10.60 0.047
0.004 5.60 1.98–15.80 0.001
0.11 2.56 0.83–7.86 0.10
0.36 1.01 0.96– 1.05 0.85
0.11 1.80 0.61–5.32 0.29
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817ifference of selection of guided method between operators,
his study’s results are subject to selection bias. It is not a
irect comparison of IVUS and FFR within the same
atients, attempting to see which patients would be accept-
ble for PCI using each technology. Third, the number of
atients included in the study was small and the duration of
he follow-up was relatively short considering the low event
ate at 1-year follow-up. Therefore, these results should be
onfirmed by larger randomized studies with a longer
ollow-up period. Fourth, the consequences of the multi-
ariate test could be overfitted, because the parameters were
elected when p value was 0.5 in univariate analysis.
onclusions
oth FFR- and IVUS-guided PCI for intermediate coro-
ary artery disease were associated with favorable outcomes.
he FFR-guided PCI reduces the need for revascularization
f many of these lesions.
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